Evidence map›Paper›PMID 40437478›Full record

ReviewBMC health services research2025

Addressing the HIV/AIDS investment gap through stronger public financial management systems: a human-centered approach.

Carlyn Mann, Elan Reuben, Susanna Baker, Mai Hijazi, A K Nandakumar, Padma Shetty, Rob Stanley, Onyeka Igboelina, Godfrey Nyombi, Dhimn Nzoya and 10 more

Abstract readReview
In one paragraph

Review in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Carlyn MannOffice of HIV/AIDS, Global Health Bureau, U.S. Agency for International Development, Washington D.C, USA. cmann@usaid.gov.ORCID http://orcid.org/0000-0001-6445-507X
Elan ReubenOffice of HIV/AIDS, Global Health Bureau, U.S. Agency for International Development, Washington D.C, USA.
Susanna BakerOffice of HIV/AIDS, Global Health Bureau, U.S. Agency for International Development, Washington D.C, USA.
Mai HijaziOffice of HIV/AIDS, Global Health Bureau, U.S. Agency for International Development, Washington D.C, USA.
A K NandakumarOffice of U.S. Global AIDS Coordinator, Washington D.C, USA.
Padma ShettyOffice of Infectious Disease, Global Health Bureau, U.S. Agency for International Development, Washington D.C, USA.
Rob StanleyHealth Office, USAID Tanzania, U.S. Agency for International Development, Dar Es Salaam, Tanzania.
Onyeka IgboelinaOffice of HIV/AIDS and Tuberculosis, USAID Nigeria, U.S. Agency for International Development, Abuja, Nigeria.
Godfrey NyombiHealth Office, USAID Tanzania, U.S. Agency for International Development, Dar Es Salaam, Tanzania.
Dhimn NzoyaHealth Office, USAID Kenya, U.S. Agency for International Development, Nairobi, Kenya.
Samson OliHealth Office, USAID Ethiopia, U.S. Agency for International Development, Addis Ababa, Ethiopia.
Garoma KenaHealth & HIV/AIDS Office, USAID Uganda, U.S. Agency for International Development, Kampala, Uganda.
Carolina PiñaHealth Office, USAID Dominican Republic, U.S. Agency for International Development, Santo Domingo, Dominican Republic.
Jordan TuchmanHealth Office, USAID, U.S. Agency for International Development, Windhoek, Namibia.
Kenneth SklawHealth Office, USAID, U.S. Agency for International Development, Gaborone, Botswana.
Abimbola Kola-JebutuHealth Office, USAID, U.S. Agency for International Development, Gaborone, Botswana.
Ivana LoharOffice of Health and Family Planning, USAID , U.S. Agency for International Development, Nepal, Kathmandu.
Anh Nguyen Thi CamHealth Office, USAID Vietnam, U.S. Agencies for International Development, Hanoi, Vietnam.
Simplice Takoubo KamdemHealth Office, USAID Côte d'Ivoire, U.S. Agency for International Development, Abidjan, Côte d'Ivoire.
Yves Maxime Kouadio KouadioHealth Office, USAID Côte d'Ivoire, U.S. Agency for International Development, Abidjan, Côte d'Ivoire.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUNAIDS estimated that US$29 billion will be required by 2025 to meet HIV/AIDS service demands, with 53 percent expected to come from domestic sources. The PEPFAR-funded, USAID-implemented Sustainable Financing Initiative for HIV/AIDS (SFI), starting in 2014, supported domestic resources mobilization efforts and activities to strengthen countries' public financial management (PFM) systems, positively contributing to much-needed increase in domestic resources for health and HIV. PROGRAM APPROACH: SFI was implemented in 12 countries, supporting activities to build the capacity of governments to mobilize domestic resources for HIV, improve budget absorption, and maximize resource use and develop and use evidence for advocacy to increase domestic government funds for HIV/AIDS. SFI measured impact by agreed upon indicators and estimated return on investment (ROI).

resultsEight countries focused on building capacity to improve budgeting and execution of health and HIV/AIDS funds; five experienced increases in budget allocation and spending. Kenya country governments spent an additional US$180 million and US$8.7 million on health and HIV, respectively. This contributed to US$60 mobilized and spent for every SFI dollar invested. Eight countries focused on using evidence to advocate for more domestic resources for health and HIV/AIDS from government budgets, increase budget execution, and identify areas for efficiency. Cambodia saw an increase in government commitments for ARVs from US$1.5 million annually from 2018-2020 to US$5 million by 2023. LESSONS LEARNED: Robust data are needed for evidence-based advocacy to increase domestic government funding for HIV/AIDS and to strengthen PFM systems for more efficient and effective resource use; institutionalizing capacity building efforts allows for locally-led technical assistance; policy-related work is a multi-year endeavor; PFM success can be stymied by political transitions, political will, and donor commitments; COVID-19 brought new challenges and new opportunities; measurable results can lead to greater impact; and results are not necessarily solely project attributions with possible inflation of ROI estimates given there was no counterfactual.

conclusionStrengthening PFM systems can increase domestic resources for health and HIV through increased revenue and improved efficiency; closing the investment gap to end the HIV/AIDS epidemic by 2030.

Indexed as

Financial ManagementFinancing, GovernmentHIV InfectionsInvestmentsAcquired Immunodeficiency SyndromeBudgetsCapacity BuildingCOVID-19HumansHealth financingHealth systemsHIV/AIDSPEPFARPublic financial managementSustainable financing

Identifiers

PMID40437478
PMCPMC12117667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.